Skip to main content
logo
Genus plc (GENSF)
OTCMKTS · Delayed Price · Currency is USD
37.25
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST

Genus Revenue

In the fiscal year ending June 30, 2025, Genus had annual revenue of 672.80M GBP with 0.60% growth. Genus had revenue of 336.40M in the half year ending June 30, 2025, a decrease of -0.91%.

Revenue
672.80M GBP
Revenue Growth
+0.60%
P/S Ratio
3.05
Revenue / Employee
210.91K GBP
Employees
3,190
Market Cap
2.81B USD

Revenue Chart

* This company reports financials in GBP.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 2025672.80M4.00M0.60%
Jun 30, 2024668.80M-20.90M-3.03%
Jun 30, 2023689.70M96.30M16.23%
Jun 30, 2022593.40M19.10M3.33%
Jun 30, 2021574.30M22.90M4.15%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BioStem Technologies292.21M
Vaxart148.20M
Silence Therapeutics25.83M
Nuo Therapeutics2.61M
Northwest Biotherapeutics937.00K
ZIVO Bioscience209.03K
Arch Biopartners198.11K
Revenue Rankings

Genus News

More News